Ireland is one of Europe’s largest MedTech hotspots and, as a globally recognised centre of excellence, is home to 300+ companies, employing 32.000 people. Nine of the world's top ten companies have operations here. Ireland also employs the highest number of MedTech personnel per capita in Europe.
Ireland’s MedTech sector has become one of the leading clusters for medical device products globally. Exports of medical devices and diagnostic products now represent 8% of Ireland's total merchandise exports.
30 million people
2nd largest exporter
Ireland is home to a closely knit cluster of 300+ MedTech companies, supported by industry, academic, clinical and government agencies. This integrated and progressive community has already encouraged an increasing number of companies to expand operations across multiple facilities.
With the highest number of personnel per capita employed in MedTech in Europe, Ireland has a deep pool of experienced and highly trained technical and managerial talent. Key areas of specific excellence include mechanical, electronic, materials engineering and science specialists.
Ireland is ranked number one globally for the most highly employable graduates. The MedTech sector benefits from this flow of skilled graduates produced by Ireland’s seven universities and 13 Institutes of Technology. Close cooperation between industry and academic institutions ensures the evolving skill needs of sector are constantly met.
As the second largest exporter of MedTech products in Europe, Ireland supplies 95 of the world’s top 100 countries (ranked by GDP). Over 25% of the world’s population that have diabetes rely on injection devices made in Ireland. An impressive 50% of ventilators in acute hospitals worldwide are manufactured in Ireland. While 33% of the global supply of contact lenses are made here.
Ireland’s exemplary regulatory environment continues to play a key role in attracting global MedTech companies. Regulation agencies work closely not only with the industry as a whole but also with individual companies to ensure compliance and trouble-free start-ups.
Ireland boasts five clinical research facilities, which support patient-focused research and is ranked number one globally for the exchange of technology and ideas. This supportive environment and generous government grant assistance is responsible for an impressive 70% of MedTech companies in Ireland engaging in research and development activities.
The key driving force behind the stunning success of Ireland’s globally recognised MedTech sector has been active collaboration between companies. Over 25% of companies have a shared services mandate, helping the sector develop world-class operations and technology solution development. The industry is also closely integrated with key academic centres of excellence, including AMBER, Tyndall National Institute, BDI, SEAM and APT.
Explore publications, infographics and press releases on the current business landscape
Stryker announced today the opening of its Digital Platform Services Centre of Excellence in Dublin, Ireland, and a strategic collaboration with RCSI (Royal College of Surgeons in Ireland) to develop digital solutions for use in emergency and specialist care settings to provide more seamless care coordination for patients suffering from time critical medical emergencies.
Natus Medical Incorporated announced today the expansion of operations in Gort, County Galway with an official opening of a new Distribution Centre Located in the IDA Business Park. The new Distribution Centre is a custom-built 22,000 square foot facility that expands the existing Natus facility in Gort to over 66,000 square feet.
Boston Scientific Galway has officially opened a new facility at its Ballybrit site. The expansion facilitates increased capacity to support global product demand and also includes an industry-leading Equipment Technology Centre. The new facility is at the site of the former Digital building and the company is investing €60M in this phase of development, with over 250 people expected to be based in the new facility by the end of 2019. Boston Scientific Galway has a workforce of over 3,700 people covering all aspects of product design & manufacturing exporting more than four million life saving medical devices each year.
BD (Becton, Dickinson and Company), a leading global medical technology company, celebrated its 50th anniversary of manufacturing in its Dún Laoghaire plant.
The celebration was led by Minister of State for Higher Education and Dún Laoghaire TD, Mary Mitchell O’Connor, and senior leaders from BD and IDA Ireland. Opened in 1969, the site is central to the company’s global pen needle manufacturing operations, with more than 5 billion needles manufactured annually in Dún Laoghaire.
Stryker today announced that it is to invest over €200m in Research, Development and Innovation (RD&I) projects at three of its five Cork facilities as it continues its vigorous innovation journey to deliver next generation products and services across its Medical Surgical, Orthopaedics and Neurotechnology and Spine offerings.
Global life-science innovation leader, Allergan, which is headquartered in Ireland and operates four facilities here, has announced a €65 million capital investment programme for 2019 to facilitate the continued expansion of the company’s state-of-the art laboratories and manufacturing campuses at Westport in County Mayo and Clonshaugh in north Dublin. The Westport facility has created 63 new highly skilled jobs, bringing total employment in Ireland to more than 2,000 across the country. One in ten employees in Allergan’s global workforce is based in Ireland.
Minister of State for Trade, Employment and Business, Pat Breen TD today announced that Johnson & Johnson Vision Care (Ireland) will be adding approximately 100 new roles as part of about a €100M expansion of its manufacturing operations at its site in the National Technology Park, Plassey, Limerick.
Leading Contract Manufacturer Expands Newly Acquired Avenue Mould Solutions with Plans to Create Over 200 New Jobs
€36 million investment will position DePuy Synthes’ Irish operation at the forefront of ground-breaking health solutions
Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health,” the “Company” or “we”) today announced it will invest to expand contact lens manufacturing capacity at its Bausch + Lomb sites in Waterford, Ireland and Rochester, N.Y. The Company is adding multiple production lines at these two sites to support the manufacture of its innovative daily disposable silicone hydrogel (SiHy daily) contact lenses.
Harmac Medical Products Inc., a leader in the international contract medical device market, today marked its 20th anniversary in Castlerea with a special celebration for staff and guests.
Harmac Medical Products Ltd. was established in Ireland in 1998 to meet the service needs of its international client base. The facility strategically positions Harmac as a world-class medical device manufacturer by providing a direct presence in Europe.
Leading medical technology company Stryker celebrates 20 years in Ireland
Company operates seven sites, employing over 3,000 people
BD, a leading global medical technology company, today announced the creation of 85 new jobs for the Limerick region. The €21 million investment in BD’s new centre of excellence has already seen 100 jobs recruited for the facility in 2017 and early 2018. The announcement of these 85 additional positions will bring the total number of employees across BD’s two Limerick sites to 285.
Quidel Corporation (NASDAQ: QDEL) a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, celebrated opening its new Business Service Centre in Galway city today. The celebration marks the company’s first expansion into international facilities.
While the American medtech industry is thriving, it still must deal with challenges that include higher production costs, finding skilled staff and the ongoing issues innate to a highly regulated sector. Then there are global concerns such as competition, funding and the high cost of research. With Europe and the United States being the key markets, many U.S. medtech firms have located some of their operations in Ireland in order to take advantage of an established, flourishing life sciences sector, strong governmental support and easy access to the lucrative European market.
IDA Ireland, the inward investment agency of the Irish Government has today reported a very strong first half of 2018.
19,851 Jobs Created in FDI companies – third consecutive year of strong growth under current strategy
December 19, 2017 (Lismeehan, County Clare) Beckman Coulter, which develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing, is expanding the company’s development and manufacturing facility at Lismeehan, County Clare, creating 70 jobs over the next two to three years.
Read case studies about why Medtech companies locate in Ireland
Explore the current business landscape in Ireland and see what's happening on the ground now.
You'll find us responsive to your needs, proactive, professional and willing to go the extra mile.
We have 28 Offices worldwide helping support companies expand their operations in Ireland.